Used in biomedical research to quantify levels of human β1 integrin protein in cell lysates, serum, plasma, and other biological fluids. Enables study of cell adhesion, migration, and signaling processes involved in immune responses, cancer progression, and tissue development. Widely applied in immunology, oncology, and regenerative medicine research to assess integrin expression under different experimental conditions. Supports high-throughput screening of drug candidates targeting integrin-mediated pathways. Provides a reliable, sensitive, and specific method for monitoring β1 integrin in disease models and therapeutic development.